Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIQ - Post by User

IMV Inc > IMV Files Amendment Shelf Prospectus
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by Biotech010on Oct 16, 2020 3:48pm
317 Views
Post# 31730120

RE:IMV Files Amendment Shelf Prospectus

RE:IMV Files Amendment Shelf Prospectus
good news is coming. They had enough room in the current shelf... so something big is coming. Also, more then $60 mln in cash... with the burn rate of 6 mln per q, they have 2 years of cash. My guess... Merck is going for a deal in DLBCL and wants to invest in equity.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities